232 related articles for article (PubMed ID: 11466256)
1. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
Watson PG; Barnett MF; Parker V; Haybittle J
Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
[TBL] [Abstract][Full Text] [Related]
2. Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma.
Collignon-Brach J
Surv Ophthalmol; 1994 May; 38 Suppl():S149-55. PubMed ID: 7940136
[TBL] [Abstract][Full Text] [Related]
3. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
Ohtake Y; Tanino T; Kimura I; Mashima Y; Oguchi Y
Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
[TBL] [Abstract][Full Text] [Related]
4. Influence of topical betaxolol and timolol on visual field in Japanese open-angle glaucoma patients.
Araie M; Azuma I; Kitazawa Y
Jpn J Ophthalmol; 2003; 47(2):199-207. PubMed ID: 12738555
[TBL] [Abstract][Full Text] [Related]
5. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
Vainio-Jylhä E; Vuori ML
Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects.
Mirza GE; Karaküçük S; Temel E
J Glaucoma; 2000 Feb; 9(1):45-50. PubMed ID: 10708231
[TBL] [Abstract][Full Text] [Related]
7. The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol.
Miki H; Miki K
J Ocul Pharmacol Ther; 2004 Dec; 20(6):509-17. PubMed ID: 15684810
[TBL] [Abstract][Full Text] [Related]
8. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
Brooks AM; Gillies WE
Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
Dobre X
Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
[TBL] [Abstract][Full Text] [Related]
10. Early Manifest Glaucoma Trial: design and baseline data.
Leske MC; Heijl A; Hyman L; Bengtsson B
Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
[TBL] [Abstract][Full Text] [Related]
11. Influence of carteolol and timolol on IOP an visual fields in glaucoma: a multi-center, double-masked, prospective study.
Flammer J; Kitazawa Y; Bonomi L; Mills B; Fsadni M; Dorigo MT; Shirato S; Journel B; Chavy B; Chevallier B
Eur J Ophthalmol; 1992; 2(4):169-74. PubMed ID: 1490088
[TBL] [Abstract][Full Text] [Related]
12. Longterm visual field follow-up of glaucoma patients treated with beta-blockers.
Kaiser HJ; Flammer J; Stümpfig D; Hendrickson P
Surv Ophthalmol; 1994 May; 38 Suppl():S156-9; discussion S160. PubMed ID: 7940137
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma.
Drance SM
J Glaucoma; 1998 Aug; 7(4):247-52. PubMed ID: 9713782
[TBL] [Abstract][Full Text] [Related]
14. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.
Grieshaber MC; Flammer J
Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652
[TBL] [Abstract][Full Text] [Related]
15. Early visual field changes with beta-blocking agents.
Collignon-Brach J
Surv Ophthalmol; 1989 Apr; 33 Suppl():429-30; discussion 435-6. PubMed ID: 2568695
[No Abstract] [Full Text] [Related]
16. Influence of betaxolol and timolol on the visual fields of patients with glaucoma.
Messmer C; Flammer J; Stümpfig D
Am J Ophthalmol; 1991 Dec; 112(6):678-81. PubMed ID: 1957903
[TBL] [Abstract][Full Text] [Related]
17. Influence of betaxolol and timolol on the venous tone in glaucoma patients.
Bojic L; Bagatin J; Ivanisevic M; Hozo I; Racic G; Karelovic D
Int Ophthalmol; 1999; 23(3):149-53. PubMed ID: 11456252
[TBL] [Abstract][Full Text] [Related]
18. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow.
Rainer G; Dorner GT; Garhöfer G; Vass C; Pfleger T; Schmetterer L
Ophthalmologica; 2003; 217(4):288-93. PubMed ID: 12792136
[TBL] [Abstract][Full Text] [Related]
19. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Frishman WH; Fuksbrumer MS; Tannenbaum M
J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
[TBL] [Abstract][Full Text] [Related]
20. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
